Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Schmitt

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|March 12, 2008
Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureusLi-Yan Yin, Jason H Calhoun, Jacob K Thomas, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2011
In vitro and in vivo properties of BAL30376, a β-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple β-lactamasesMalcolm G P Page, Clothilde Dantier, Eric Desarbre, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2013
Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilliBeatrice Hofer, Clothilde Dantier, Klaus Gebhardt, et al.
Bioconjugate Chemistry|May 3, 2011
Directed covalent immobilization of fluorescently labeled cytokinesTobias Recker, Daniel Haamann, Anne Schmitt, et al.
Anesthesiology|January 24, 2004
Alterations in rat brain proteins after desflurane anesthesiaCarsten D Fütterer, Martin H Maurer, Anne Schmitt, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2006
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavusPeter A Warn, Andrew Sharp, Juan Mosquera, et al.
Journal of Cell Science|February 18, 2011
The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3Michael Vogt, Tamas Domoszlai, Dzina Kleshchanok, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteersAnne Schmitt-Hoffmann, Brigitte Roos, Jürgen Maares, et al.
Talanta|January 31, 2026
μ-LIBS imaging of archaeological ceramics: Quantification of clay fraction in provenance studyNicolas Herreyre, Valérie Thirion-Merle, Loan Lemaître, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteersAnne Schmitt-Hoffmann, Brigitte Roos, Markus Heep, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|March 12, 2008
Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureusLi-Yan Yin, Jason H Calhoun, Jacob K Thomas, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2011
In vitro and in vivo properties of BAL30376, a β-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple β-lactamasesMalcolm G P Page, Clothilde Dantier, Eric Desarbre, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2013
Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilliBeatrice Hofer, Clothilde Dantier, Klaus Gebhardt, et al.
Bioconjugate Chemistry|May 3, 2011
Directed covalent immobilization of fluorescently labeled cytokinesTobias Recker, Daniel Haamann, Anne Schmitt, et al.
Anesthesiology|January 24, 2004
Alterations in rat brain proteins after desflurane anesthesiaCarsten D Fütterer, Martin H Maurer, Anne Schmitt, et al.
The Journal of Antimicrobial Chemotherapy|October 31, 2006
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavusPeter A Warn, Andrew Sharp, Juan Mosquera, et al.
Journal of Cell Science|February 18, 2011
The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3Michael Vogt, Tamas Domoszlai, Dzina Kleshchanok, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteersAnne Schmitt-Hoffmann, Brigitte Roos, Jürgen Maares, et al.
Talanta|January 31, 2026
μ-LIBS imaging of archaeological ceramics: Quantification of clay fraction in provenance studyNicolas Herreyre, Valérie Thirion-Merle, Loan Lemaître, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteersAnne Schmitt-Hoffmann, Brigitte Roos, Markus Heep, et al.
Pageof 5